Hannah K Choe

4PUBLICATIONS
42CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiovascular medicine and haematology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 19, 2025
Presence of Clonal Hematopoiesis and Cardiac Events After Allogeneic Stem Cell Transplantation.

Cooper Quartermaine, Zach Braunstein, Adnan Shaaban

|Mar 22, 2025
DHODH inhibition alters T cell metabolism limiting acute graft-versus-host disease while retaining graft-versus-leukemia response.

Rathan Kumar, Kara M Braunreiter, Lotus Neidemire-Colley

|Sep 19, 2024
Randomized Phase III SIERRA Trial of 131I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML.

Boglarka Gyurkocza, Rajneesh Nath, Stuart Seropian

|Aug 16, 2024
A Multicenter Phase II Trial of Ruxolitinib for Treatment of Corticosteroid Refractory Sclerotic Chronic Graft-Versus-Host Disease.

Vijaya Raj Bhatt, Valerie K Shostrom, Hannah K Choe

Pageof 1